PTEN and NEDD4 in Human Breast Carcinoma

[1]  Mingming Jia,et al.  COSMIC: exploring the world's knowledge of somatic mutations in human cancer , 2014, Nucleic Acids Res..

[2]  Xuejun Jiang,et al.  PTEN is a protein tyrosine phosphatase for IRS1 , 2014, Nature Structural &Molecular Biology.

[3]  J. Gunnersen,et al.  Ndfip1 expression in developing neurons indicates a role for protein ubiquitination by Nedd4 E3 ligases during cortical development , 2013, Neuroscience Letters.

[4]  J. Moon,et al.  p34 is a novel regulator of the oncogenic behavior of NEDD4-1 and PTEN , 2013, Cell Death and Differentiation.

[5]  N. Lu,et al.  Is NEDD4-1 a negative regulator of phosphatase and tensin homolog in gastric carcinogenesis? , 2012, World journal of gastroenterology.

[6]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[7]  J. Penninger,et al.  E3 ubiquitin ligase Cbl-b regulates Pten via Nedd4 in T cells independently of its ubiquitin ligase activity. , 2012, Cell reports.

[8]  Yusuke Nakamura,et al.  Possible involvement of NEDD4 in keloid formation; its critical role in fibroblast proliferation and collagen production , 2011, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[9]  J. Sarkaria,et al.  WWP2 is an E3 ubiquitin ligase for PTEN , 2011, Nature Cell Biology.

[10]  Ali N. Salman,et al.  Tumorigenesis and Neoplastic Progression Oncogenic Role of the E 3 Ubiquitin Ligase NEDD 4-1 , a PTEN Negative Regulator , in Non-Small-Cell Lung Carcinomas , 2010 .

[11]  C. Holt,et al.  E3 Ligase Nedd4 Promotes Axon Branching by Downregulating PTEN , 2010, Neuron.

[12]  C. Eng,et al.  PTEN hamartoma tumor syndrome: An overview , 2009, Genetics in Medicine.

[13]  Xinjiang Wang,et al.  Post-translational regulation of PTEN , 2008, Oncogene.

[14]  V. Stambolic,et al.  The ubiquitin ligase Nedd4-1 is dispensable for the regulation of PTEN stability and localization , 2008, Proceedings of the National Academy of Sciences.

[15]  Chae Young Hwang,et al.  The tumour suppressor PTEN mediates a negative regulation of the E3 ubiquitin-protein ligase Nedd4. , 2008, The Biochemical journal.

[16]  M. Ringnér,et al.  Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity , 2007, Proceedings of the National Academy of Sciences.

[17]  P. Pandolfi,et al.  NEDD4-1 Is a Proto-Oncogenic Ubiquitin Ligase for PTEN , 2007, Cell.

[18]  Tom Misteli,et al.  Ubiquitination Regulates PTEN Nuclear Import and Tumor Suppression , 2007, Cell.

[19]  L. Cantley,et al.  Ras, PI(3)K and mTOR signalling controls tumour cell growth , 2006, Nature.

[20]  Hanina Hibshoosh,et al.  PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma. , 2005, Cancer research.

[21]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[22]  R. Parsons,et al.  PTEN: life as a tumor suppressor. , 2001, Experimental cell research.

[23]  Tomohiko Maehama,et al.  The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate* , 1998, The Journal of Biological Chemistry.

[24]  V. McKusick,et al.  Deletion of PTEN in a patient with Bannayan-Riley-Ruvalcaba syndrome suggests allelism with Cowden disease. , 1997, American journal of medical genetics.

[25]  Jing Li,et al.  Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome , 1997, Nature Genetics.

[26]  W. K. Alfred Yung,et al.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers , 1997, Nature Genetics.

[27]  M. Wigler,et al.  PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.

[28]  R. Lothe,et al.  NEDD4 is overexpressed in colorectal cancer and promotes colonic cell growth independently of the PI3K/PTEN/AKT pathway. , 2013, Cellular signalling.

[29]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[30]  L. Saal,et al.  Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair , 2008, Nature Genetics.

[31]  Van,et al.  A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.